A range of organizations are forming a new advocacy group, the Long COVID Alliance, to push for greater funding and research into patients who suffer Covid symptoms long after they’re free of the virus.
The coalition is making a series of recommendations for how the NIH should spend an initial $1.15 billion allocated for long-term Covid studies, and calling on the agency to prioritize health equity and the creation of a pipeline to translate research into treatments for longer-term health problems caused by Covid.
— Who’s backing the alliance: Solve M.E., the National Health Council and the Open Medicine Foundation are among the 50 groups signed on as partners in the initiative.
This article originally appeared in POLITICO.
